Cargando…
Non-Traditional Systemic Treatments for Diabetic Retinopathy: An Evidence-Based Review
The rapid escalation in the global prevalence diabetes, with more than 30% being afflicted with diabetic retinopathy (DR), means it is likely that associated vision-threatening conditions will also rise substantially. This means that new therapeutic approaches need to be found that go beyond the cur...
Autores principales: | Simó, Rafael, Ballarini, Stefania, Cunha-Vaz, José, Ji, Linong, Haller, Hermann, Zimmet, Paul, Wong, Tien Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997935/ https://www.ncbi.nlm.nih.gov/pubmed/25989912 http://dx.doi.org/10.2174/0929867322666150520095923 |
Ejemplares similares
-
Characterization of Risk Profiles for Diabetic Retinopathy Progression
por: Cunha-Vaz, José, et al.
Publicado: (2021) -
State-of-the-Art Research on Diabetic Retinopathy
por: Simó, Rafael
Publicado: (2022) -
Longitudinal Association of Glucose Metabolism With Retinopathy: Results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study
por: Tapp, Robyn J., et al.
Publicado: (2008) -
Serum Apolipoprotein AI and B Are Stronger Biomarkers of Diabetic Retinopathy Than Traditional Lipids
por: Sasongko, Muhammad Bayu, et al.
Publicado: (2011) -
Advances in the Medical Treatment of Diabetic Retinopathy
por: Simó, Rafael, et al.
Publicado: (2009)